CINCINNATI and SEOUL, South Korea, Jan. 31, 2023 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, and ...
There's no foolproof way to know the future for Meridian Bioscience (NASDAQ: VIVO) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before ...
MONHEIM AM RHEIN, Germany--(BUSINESS WIRE)--Resolve Biosciences, the pioneer in Molecular Cartography™ technology, today announced the expansion of its end-to-end Meridian service offering for spatial ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Meridian Bioscience has made ...
CINCINNATI, April 23, 2025 /PRNewswire/ -- The Life Science division of Meridian Bioscience, Inc., a leading global manufacturer of diagnostics and life science raw materials, today announced the ...
Three months ended September 30, 2022 and 2021 do not sum to total due to rounding. Three months ended September 30, 2022 does not sum to total due to rounding. The Revogene ® SARS-CoV-2 product has ...
(Reuters) - The U.S. Food and Drug Administration approved on Friday the first test - a diagnostic from Meridian Bioscience Inc - to help detect a type of herpes virus in newborns. Meridian's Alethia ...
Meridian Bioscience subsidiary Magellan Diagnostics was previously ordered to pay $42 million for selling the tests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results